{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Achillea millefolium L.", "Apoptosis", "Clostridioides difficile", "Extracts", "Inflammation", "Ribotype 001", "Tox-S"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38218845", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "18"}, "Article": {"Language": ["eng"], "ELocationID": ["37", "10.1186/s12906-024-04335-2"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "13"}], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "13"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "The anti-inflammatory and anti-apoptotic effects of Achillea millefolium L. extracts on Clostridioides difficile ribotype 001 in human intestinal epithelial cells.", "Pagination": {"StartPage": "37", "MedlinePgn": "37"}, "Abstract": {"AbstractText": ["Clostridioides difficile infection (CDI) is one of the most common health care-acquired infections. The dramatic increase in antimicrobial resistance of C. difficile isolates has led to growing demand to seek new alternative medicines against CDI. Achillea millefolium L. extracts exhibit strong biological activity to be considered as potential therapeutic agents. In this work, the inhibitory effects of A. millefolium, its decoction (DEC) and ethanol (ETOH) extracts, were investigated on the growth of C. difficile RT001 and its toxigenic cell-free supernatant (Tox-S) induced inflammation and apoptosis.", "Phytochemical analysis of extracts was performed by HPLC and GC analysis. The antimicrobial properties of extracts were evaluated against C. difficile RT001. Cell viability and cytotoxicity of Caco-2 and Vero cells treated with various concentrations of extracts and Tox-S were examined by MTT assay and microscopy, respectively. Anti-inflammatory and anti-apoptotic effects of extracts were assessed in Tox-S stimulated Caco-2 cells by RT-qPCR.", "Analysis of the phytochemical profile of extracts revealed that the main component identified in both extracts was chlorogenic acid. Both extracts displayed significant antimicrobial activity against C. difficile RT001. Moreover, both extracts at concentration 50 \u00b5g/mL had no significant effect on cell viability compared to untreated cells. Pre-treatment of cells with extracts (50 \u00b5g/mL) significantly reduced the percentage of Vero cells rounding induced by Tox-S. Also, both pre-treatment and co-treatment of Tox-S stimulated Caco-2 cells with extracts significantly downregulated the gene expression level of IL-8, IL-1\u03b2, TNF-\u03b1, TGF-\u03b2, iNOS, Bax, caspase-9 and caspase-3 and upregulated the expression level of Bcl-2.", "The results of the present study for the first time demonstrate the antimicrobial activity and protective effects of A. millefolium extracts on inflammatory response and apoptosis induced by Tox-S from C. difficile RT001 clinical strain in vitro. Further research is needed to evaluate the potential application of A. millefolium extracts as supplementary medicine for CDI prevention and treatment in clinical setting."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Raeisi", "ForeName": "Hamideh", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Azimirad", "ForeName": "Masoumeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Division, Research Institute of Forests and Rangelands, Agricultural Research, Education & Extension Organization (AREEO), Tehran, Iran."}], "LastName": "Asadi-Sanam", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Asadzadeh Aghdaei", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": ["0000-0002-2135-7581"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. a.yadegar@sbmu.ac.ir."}], "LastName": "Yadegar", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Zali", "ForeName": "Mohammad Reza", "Initials": "MR"}], "GrantList": [{"GrantID": "RIGLD 1138", "Agency": "Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Clostridioides difficile"}, {"QualifierName": [], "DescriptorName": "Caco-2 Cells"}, {"QualifierName": [], "DescriptorName": "Ribotyping"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": ["chemistry", "genetics"], "DescriptorName": "Achillea"}, {"QualifierName": [], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": [], "DescriptorName": "Phytochemicals"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181\u2013206. doi: 10.1016/j.disamonth.2015.01.006.", "ArticleIdList": ["10.1016/j.disamonth.2015.01.006", "PMC4402243", "25769243"]}, {"Citation": "SmitsW K, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2(1):16020. doi: 10.1038/nrdp.2016.20.", "ArticleIdList": ["10.1038/nrdp.2016.20", "PMC5453186", "27158839"]}, {"Citation": "Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369\u201370. doi: 10.1056/NEJMc1505190.", "ArticleIdList": ["10.1056/NEJMc1505190", "26061850"]}, {"Citation": "Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021;116(6):1124\u201347. doi: 10.14309/ajg.0000000000001278.", "ArticleIdList": ["10.14309/ajg.0000000000001278", "34003176"]}, {"Citation": "Mullish BH, Williams HR. Clostridium difficile infection and antibiotic-associated diarrhoea. Clin Med. 2018;18(3):237\u201341. doi: 10.7861/clinmedicine.18-3-237.", "ArticleIdList": ["10.7861/clinmedicine.18-3-237", "PMC6334067", "29858434"]}, {"Citation": "Chen S, Sun C, Wang H, Wang J. The role of rho gtpases in toxicity of Clostridium difficile toxins. Toxins. 2015;7(12):5254\u201367. doi: 10.3390/toxins7124874.", "ArticleIdList": ["10.3390/toxins7124874", "PMC4690124", "26633511"]}, {"Citation": "Saavedra PHV, Huang L, Ghazavi F, Kourula S, Vanden Berghe T, Takahashi N, Vandenabeele P, Lamkanfi M. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis. Nat Commun. 2018;9(1):4846. doi: 10.1038/s41467-018-07386-5.", "ArticleIdList": ["10.1038/s41467-018-07386-5", "PMC6242954", "30451870"]}, {"Citation": "Shen A. Clostridium difficile toxins: mediators of inflammation. J Innate Immun. 2012;4(2):149\u201358. doi: 10.1159/000332946.", "ArticleIdList": ["10.1159/000332946", "PMC3388264", "22237401"]}, {"Citation": "Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev. 2017;3(3):CD004610\u20130. doi: 10.1002/14651858.CD004610.pub5.", "ArticleIdList": ["10.1002/14651858.CD004610.pub5", "PMC6464548", "28257555"]}, {"Citation": "Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK. Fidaxomicin versus Vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422\u201331. doi: 10.1056/NEJMoa0910812.", "ArticleIdList": ["10.1056/NEJMoa0910812", "21288078"]}, {"Citation": "D\u2019Agostino RB, Collins SH, Pencina KM, Kean Y, Gorbach S. Risk estimation for recurrent clostridium difficile infection based on clinical factors. Clin Infect Dis. 2014;58(10):1386\u201393. doi: 10.1093/cid/ciu107.", "ArticleIdList": ["10.1093/cid/ciu107", "24599770"]}, {"Citation": "Mullane K. Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance. Ther Adv Chronic Dis. 2014;5(2):69\u201384. doi: 10.1177/2040622313511285.", "ArticleIdList": ["10.1177/2040622313511285", "PMC3926343", "24587892"]}, {"Citation": "Stranges PM, Hutton DW, Collins CD. Cost-effectiveness analysis evaluating fidaxomicin versus oral Vancomycin for the treatment of Clostridium difficile infection in the United States. Value Health. 2013;16(2):297\u2013304. doi: 10.1016/j.jval.2012.11.004.", "ArticleIdList": ["10.1016/j.jval.2012.11.004", "23538181"]}, {"Citation": "Azimirad M, Yadegar A, Gholami F, Shahrokh S, Asadzadeh Aghdaei H, Ianiro G, Suzuki H, Cammarota G, Zali MR. Treatment of recurrent Clostridioides difficile infection using fecal microbiota transplantation in Iranian patients with underlying inflammatory bowel disease. J Inflamm Res. 2020;13:563\u201370. doi: 10.2147/JIR.S265520.", "ArticleIdList": ["10.2147/JIR.S265520", "PMC7509309", "32982371"]}, {"Citation": "Raeisi H, Azimirad M, Nabavi-Rad A, Asadzadeh Aghdaei H, Yadegar A, Zali MR. Application of recombinant antibodies for treatment of Clostridioides difficile infection: current status and future perspective [Review]. Front Immunol. 2022;13. 10.3389/fimmu.2022.972930.", "ArticleIdList": ["PMC9445313", "36081500"]}, {"Citation": "Lee J, Choi HS, Lee J, Park J, Kim SB, Shin MS, Lee S, Hwang GS, Koo BA, KangKS. Preparation of herbal formulation for inflammatory bowel disease based on in vitro screening and in vivo evaluation in a mouse model of experimental colitis. Molecules. 2019;24(3). 10.3390/molecules24030464.", "ArticleIdList": ["PMC6384830", "30696085"]}, {"Citation": "Kalaiselvan S, Rasool MK. Triphala herbal extract suppresses inflammatory responses in LPS-stimulated RAW 264.7 macrophages and adjuvant-induced arthritic rats via inhibition of NF-\u03baB pathway. J Immunotoxicol. 2016;13(4):509\u201325. doi: 10.3109/1547691x.2015.1136010.", "ArticleIdList": ["10.3109/1547691x.2015.1136010", "27438966"]}, {"Citation": "Villalva M, Jaime L, Villanueva-Bermejo D, Lara B, Fornari T, Reglero G, Santoyo S. Supercritical anti-solvent fractionation for improving antioxidant and anti-inflammatory activities of an Achillea millefolium L. extract. Food Res Int. 2019;115:128\u201334. doi: 10.1016/j.foodres.2018.08.027.", "ArticleIdList": ["10.1016/j.foodres.2018.08.027", "30599924"]}, {"Citation": "Wang L, Du H, Chen P. Chlorogenic acid inhibits the proliferation of human lung cancer A549 cell lines by targeting annexin A2 in vitro and in vivo. Biomed Pharmacother. 2020;131:110673. doi: 10.1016/j.biopha.2020.110673.", "ArticleIdList": ["10.1016/j.biopha.2020.110673", "32882585"]}, {"Citation": "Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitis. Saudi. J Gastroenterol. 2012;18(1):3\u201310. doi: 10.4103/1319-3767.91726.", "ArticleIdList": ["10.4103/1319-3767.91726", "PMC3271691", "22249085"]}, {"Citation": "Witaicenis A, Seito LN, da Silveira Chagas A, de Almeida LD, Luchini AC, Rodrigues-Orsi P, Cestari SH, Di Stasi LC. Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine. 2014;21(3):240\u20136. doi: 10.1016/j.phymed.2013.09.001.", "ArticleIdList": ["10.1016/j.phymed.2013.09.001", "24176844"]}, {"Citation": "Zhang LC, Wang Y, Tong LC, Sun S, Liu WY, Zhang S, Wang RM, Wang ZB, Li L. Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Exp Ther Med. 2017;13(6):3374\u201382. doi: 10.3892/etm.2017.4402.", "ArticleIdList": ["10.3892/etm.2017.4402", "PMC5450762", "28587416"]}, {"Citation": "Naz R, Ayub H, Nawaz S, Islam ZU, Yasmin T, Bano A, Wakeel A, Zia S, Roberts TH. Antimicrobial activity, toxicity and anti-inflammatory potential of methanolic extracts of four ethnomedicinal plant species from Punjab, Pakistan. BMC Complement Altern Med. 2017;17(1):302. doi: 10.1186/s12906-017-1815-z.", "ArticleIdList": ["10.1186/s12906-017-1815-z", "PMC5465528", "28595608"]}, {"Citation": "Ivanovi\u0107 M, Gruji\u0107 D, Cerar J, Islam\u010devi\u0107 Razbor\u0161ek M, Topali\u0107-Trivunovi\u0107 L, Savi\u0107 A, Ko\u010dar D, Kolar M. Extraction of bioactive metabolites from Achillea millefolium L. with choline chloride based natural deep eutectic solvents: a study of the antioxidant and antimicrobial activity. Antioxidants. 2022;11(4). 10.3390/antiox11040724.", "ArticleIdList": ["PMC9027353", "35453409"]}, {"Citation": "Strz\u0119pek-Gom\u00f3\u0142ka M, Gawe\u0142-B\u0119ben K, Kukula-Koch W. Achillea Species as sources of active phytochemicals for dermatological and cosmetic applications. Oxid Med Cell Longev. 2021 doi: 10.1155/2021/6643827.", "ArticleIdList": ["10.1155/2021/6643827", "PMC8018854", "33833853"]}, {"Citation": "Saeidnia S, Gohari A, Mokhber-Dezfuli N, Kiuchi F. A review on phytochemistry and medicinal properties of the genus Achillea. Daru. 2011;19(3):173\u201386.", "ArticleIdList": ["PMC3232110", "22615655"]}, {"Citation": "Bitwell C, Indra SS, Luke C, Kakoma MK. A review of modern and conventional extraction techniques and their applications for extracting phytochemicals from plants. Sci Afr. 2023;19:e01585. doi: 10.1016/j.sciaf.2023.e01585.", "ArticleIdList": ["10.1016/j.sciaf.2023.e01585"]}, {"Citation": "Candan F, Unlu M, Tepe B, Daferera D, Polissiou M, S\u00f6kmen A, Akpulat HA. Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae) J Ethnopharmacol. 2003;87(2):215\u201320. doi: 10.1016/S0378-8741(03)00149-1.", "ArticleIdList": ["10.1016/S0378-8741(03)00149-1", "12860311"]}, {"Citation": "El-Kalamouni C, Venskutonis PR, Zebib B, Merah O, Raynaud C, Talou T. Antioxidant and antimicrobial activities of the essential oil of Achillea millefolium L. grown in France. Medicines. 2017;4(2). 10.3390/medicines4020030.", "ArticleIdList": ["PMC5590066", "28930245"]}, {"Citation": "Potrich FB, Allemand A, da Silva LM, dos Santos AC, Baggio CH, Freitas CS, Mendes DAGB, Andre E, De Paula Werner MF, Marques MCA. Antiulcerogenic activity of hydroalcoholic extract of Achillea millefolium L.: involvement of the antioxidant system. J Ethnopharmacol. 2010;130(1):85\u201392. doi: 10.1016/j.jep.2010.04.014.", "ArticleIdList": ["10.1016/j.jep.2010.04.014", "20420892"]}, {"Citation": "Csupor B, Hajdu Z, Zupko I, R\u00e9thy B, Falkay G, Forgo P, Hohmann J. Antiproliferative effect of flavonoids and sesquiterpenoids from achillea millefolium s.l. on cultured human tumour cell lines. Phytother Res. 2009;23:672\u20136. doi: 10.1002/ptr.2697.", "ArticleIdList": ["10.1002/ptr.2697", "19107850"]}, {"Citation": "Lin LT, Liu LT, Chiang LC, Lin CC. In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phytother Res. 2002;16(5):440\u20134. doi: 10.1002/ptr.937.", "ArticleIdList": ["10.1002/ptr.937", "12203264"]}, {"Citation": "Li Y, Zhang ML, Cong B, Wang SM, Dong M, Sauriol F, Huo CH, Shi QW, Gu YC, Kiyota H. Achillinin a, a cytotoxic guaianolide from the flower of Yarrow, Achillea millefolium. Biosci Biotechno Biochem. 2011;75(8):1554\u20136. doi: 10.1271/bbb.110234.", "ArticleIdList": ["10.1271/bbb.110234", "21821943"]}, {"Citation": "Azimirad M, Krutova M, Yadegar A, Shahrokh S, Olfatifar M, Aghdaei HA, Fawley WN, Wilcox MH, Zali MR. Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study. Emerg Microbes Infect. 2020;9(1):1432\u201343. doi: 10.1080/22221751.2020.1780949.", "ArticleIdList": ["10.1080/22221751.2020.1780949", "PMC7473134", "32520657"]}, {"Citation": "Azimirad M, Krutova M, Balaii H, Kodori M, Shahrokh S, Azizi O, Yadegar A, Aghdaei HA, Zali MR. Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease. Anaerobe. 2020;61:102113. doi: 10.1016/j.anaerobe.2019.102113.", "ArticleIdList": ["10.1016/j.anaerobe.2019.102113", "31698044"]}, {"Citation": "Azimirad M, Noori M, Azimirad F, Gholami F, Naseri K, Yadegar A, Asadzadeh Aghdaei H, Zali MR. Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro. Ann Clin Microbiol Antimicrob. 2022;21(1):41. doi: 10.1186/s12941-022-00533-3.", "ArticleIdList": ["10.1186/s12941-022-00533-3", "PMC9511736", "36155114"]}, {"Citation": "Li S, Shi L, Yang Z, Feng H. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol. Pathog Dis. 2013;67(1):11\u20138. doi: 10.1111/2049-632X.12016.", "ArticleIdList": ["10.1111/2049-632X.12016", "PMC3742912", "23620115"]}, {"Citation": "Pike CM, Theriot CM. Mechanisms of colonization resistance against Clostridioides difficile. J Infect Dis. 2021;223(12 Suppl 2):194\u2013s200. doi: 10.1093/infdis/jiaa408.", "ArticleIdList": ["10.1093/infdis/jiaa408", "PMC8206795", "33326565"]}, {"Citation": "Baghani A, Mesdaghinia A, Kuijper EJ, Aliramezani A, Talebi M, Douraghi M. High prevalence of Clostridiodes diffiicle PCR ribotypes 001 and 126 in Iran. Sci Rep. 2020;10(1):4658. doi: 10.1038/s41598-020-61604-z.", "ArticleIdList": ["10.1038/s41598-020-61604-z", "PMC7070088", "32170182"]}, {"Citation": "Grigore A, Colceru-Mihul S, Bazdoaca C, Yuksel R, Ionita C, Glava L. Antimicrobial activity of an Achillea millefolium L. Proc. 2020;57:34. doi: 10.3390/proceedings2020057034.", "ArticleIdList": ["10.3390/proceedings2020057034"]}, {"Citation": "Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med. 2018;13:20\u20130. doi: 10.1186/s13020-018-0177-x.", "ArticleIdList": ["10.1186/s13020-018-0177-x", "PMC5905184", "29692864"]}, {"Citation": "Karaalp C, Yurtman AN, Karabay Yavasoglu NU. Evaluation of antimicrobial properties of Achillea L. flower head extracts. Pharm Biol. 2009;47(1):86\u201391. doi: 10.1080/13880200802448682.", "ArticleIdList": ["10.1080/13880200802448682"]}, {"Citation": "Turkmenoglu FP, Agar OT, Akaydin G, Hayran M, Demirci B. Characterization of volatile compounds of eleven Achillea species from Turkey and biological activities of essential oil and methanol extract of a. hamzaoglui arabac\u0131 & budak. Molecules. 2015;20(6):11432\u201358. doi: 10.3390/molecules200611432.", "ArticleIdList": ["10.3390/molecules200611432", "PMC6272225", "26111175"]}, {"Citation": "Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid.-based Complement. Altern Med. 201;3012462. 10.1155/2016/3012462.", "ArticleIdList": ["PMC5206475", "28090211"]}, {"Citation": "Raut JS, Karuppayil SM. A status review on the medicinal properties of essential oils. Ind Crops Prod. 2014;62:250\u201364. doi: 10.1016/j.indcrop.2014.05.055.", "ArticleIdList": ["10.1016/j.indcrop.2014.05.055"]}, {"Citation": "Plaskova A, Mlcek J. New insights of the application of water or ethanol-water plant extract rich in active compounds in food. Front Nutr. 2023;28(10):1118761. doi: 10.3389/fnut.2023.1118761.", "ArticleIdList": ["10.3389/fnut.2023.1118761", "PMC10086256", "37057062"]}, {"Citation": "K\u0119pa M, Miklasi\u0144ska-Majdanik M, Wojtyczka RD, Idzik D, Korzeniowski K, Smole\u0144-Dzirba J, W\u0105sik TJ. Antimicrobial potential of caffeic acid against Staphylococcus aureus clinical strains. Biomed Res Int. 2018;7413504. 10.1155/2018/7413504.", "ArticleIdList": ["PMC6076962", "30105241"]}, {"Citation": "Chen K, Peng C, Chi F, Yu C, Yang Q, Li Z. Antibacterial and antibiofilm activities of chlorogenic acid against Yersinia enterocolitica. Front Microbiol. 2022;13. 10.3389/fmicb.2022.885092.", "ArticleIdList": ["PMC9117966", "35602020"]}, {"Citation": "Wu Y, Liang S, Zhang M, Wang Z, Wang Z, Ren X. The Effect of Chlorogenic Acid on Bacillus subtilis based on Metabolomics. Molecules. 2020;25(18). 10.3390/molecules25184038.", "ArticleIdList": ["PMC7571229", "32899667"]}, {"Citation": "Huang X, Lao Y, Pan Y, Chen Y, Zhao H, Gong L, Xie N, Mo CH. Synergistic antimicrobial effectiveness of plant essential oil and its application in seafood preservation: a review. Molecules. 2021;26(2). 10.3390/molecules26020307.", "ArticleIdList": ["PMC7827451", "33435286"]}, {"Citation": "Burk D, Cichacz Z, Daskalova S. Aqueous extract of Achillea millefolium L. (Asteraceae) inflorescences suppresses lipopolysaccharide-induced inflammatory responses in RAW 264.7 murine macrophages. J Med Plant Res. 2010;4:225\u201334."}, {"Citation": "Giorgi A, Bombelli R, Luini A, Speranza G, Cosentino M, Lecchini S, Cocucci M. Antioxidant and cytoprotective properties of infusions from leaves and inflorescences of Achillea collina Becker ex Rchb. Phytother Res. 2009;23(4):540\u20135. doi: 10.1002/ptr.2679.", "ArticleIdList": ["10.1002/ptr.2679", "19067389"]}, {"Citation": "Cavalcanti AM, Baggio CH, Freitas CS, Rieck L, de Sousa RS, Da Silva-Santos JE, Mesia-Vela S, Marques MCA. Safety and antiulcer efficacy studies of Achillea millefolium L. after chronic treatment in Wistar rats. J Ethnopharmacol. 2006;107(2):277\u201384. doi: 10.1016/j.jep.2006.03.011.", "ArticleIdList": ["10.1016/j.jep.2006.03.011", "16647233"]}, {"Citation": "Zeng A, Liang X, Zhu S, Liu C, Wang S, Zhang Q, Zhao J, Song L. Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF\u2013\u03baB signaling pathway. Oncol Rep. 2021;45(2):717\u201327. doi: 10.3892/or.2020.7891.", "ArticleIdList": ["10.3892/or.2020.7891", "PMC7757108", "33416150"]}, {"Citation": "Abotaleb M, Liskova A, Kubatka P, B\u00fcsselberg D. Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules. 2020;10(2). 10.3390/biom10020221.", "ArticleIdList": ["PMC7072661", "32028623"]}, {"Citation": "Nottrott S, Schoentaube J, Genth H, Just I, Gerhard R. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of rho GTPases. Apoptosis. 2007;12(8):1443\u201353. doi: 10.1007/s10495-007-0074-8.", "ArticleIdList": ["10.1007/s10495-007-0074-8", "17437185"]}, {"Citation": "Zhang Y, Li Y, Li H, Chen W, Liu W. Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model. Biomed Pharmacother. 2018;101:391\u20138. doi: 10.1016/j.biopha.2018.02.045.", "ArticleIdList": ["10.1016/j.biopha.2018.02.045", "29501042"]}, {"Citation": "Mooyottu S, Kollanoor-Johny A, Flock G, Bouillaut L, Upadhyay A, Sonenshein AL, Venkitanarayanan K. Carvacrol and trans-cinnamaldehyde reduce Clostridium difficile toxin production and cytotoxicity in vitro. Int J Mol Sci. 2014;15(3):4415\u201330. doi: 10.3390/ijms15034415.", "ArticleIdList": ["10.3390/ijms15034415", "PMC3975404", "24625665"]}, {"Citation": "Shimamura Y, Aoki N, Sugiyama Y, Tanaka T, Murata M, Masuda S. Plant-derived polyphenols interact with staphylococcal enterotoxin a and inhibit toxin activity. PLoS ONE. 2016;11(6):e0157082. doi: 10.1371/journal.pone.0157082.", "ArticleIdList": ["10.1371/journal.pone.0157082", "PMC4896416", "27272505"]}, {"Citation": "Li Y, Xu S, Xu Q, Chen Y. Clostridium difficile toxin B induces colonic inflammation through the TRIM46/DUSP1/MAPKs and NF-\u03baB signalling pathway. Artif Cells Nanomed Biotechnol. 2020;48(1):452\u201362. doi: 10.1080/21691401.2019.1709856.", "ArticleIdList": ["10.1080/21691401.2019.1709856", "31918570"]}, {"Citation": "Xue VW, Chung JY, C\u00f3rdoba CAG, Cheung AH, Kang W, Lam EW, Leung KT, To KF, Lan HY, Tang PM. Transforming growth factor-\u03b2: a multifunctional regulator of cancer immunity. Cancers. 2020;12(11). 10.3390/cancers12113099.", "ArticleIdList": ["PMC7690808", "33114183"]}, {"Citation": "Tinoco-Veras CM, Santos AAQA, Stipursky J, Meloni M, Araujo APB, Foschetti DA, L\u00f3pez-Ure\u00f1a D, Quesada-G\u00f3mez C, Leit\u00e3o RFC, Gomes FCA. Transforming growth factor \u03b21/SMAD signaling pathway activation protects the intestinal epithelium from Clostridium difficile Toxin A-induced damage. Infect Immun. 2017;85(10):e00430\u201300417. doi: 10.1128/IAI.00430-17.", "ArticleIdList": ["10.1128/IAI.00430-17", "PMC5607421", "28784928"]}, {"Citation": "Freysdottir J, Logadottir OT, Omarsdottir SS, Vikingsson A, Hardardottir I. A polysaccharide fraction from Achillea millefolium increases cytokine secretion and reduces activation of akt, ERK and NF-\u03baB in THP-1 monocytes. Carbohydr Polym. 2016;143:131\u20138. doi: 10.1016/j.carbpol.2016.02.017.", "ArticleIdList": ["10.1016/j.carbpol.2016.02.017", "27083352"]}, {"Citation": "Chou S-T, Peng H-Y, Hsu J-C, Lin C-C, Shih Y. Achillea millefolium L. essential oil inhibits LPS-induced oxidative stress and nitric oxide production in RAW 264.7 macrophages. Int J Mol Sci. 2013;14(7):12978\u201393. doi: 10.3390/ijms140712978.", "ArticleIdList": ["10.3390/ijms140712978", "PMC3742169", "23797659"]}, {"Citation": "Muniyappa R, Xu R, Ram JL, Sowers JR. Inhibition of rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2000;278(6):H1762\u20131768. doi: 10.1152/ajpheart.2000.278.6.H1762.", "ArticleIdList": ["10.1152/ajpheart.2000.278.6.H1762", "10843870"]}, {"Citation": "Natarajan K, Abraham P, Kota R, Isaac NF-\u03baB-iNOS-COX2-TNF \u03b1 inflammatory signaling pathway plays an important role in methotrexate induced small intestinal injury in rats. Food Chem Toxicol. 2018;118:766\u201383. doi: 10.1016/j.fct.2018.06.040.", "ArticleIdList": ["10.1016/j.fct.2018.06.040", "29935243"]}, {"Citation": "Woo ER, Lee JY, Cho IJ, Kim SG, Kang KW. Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kappaB activation in macrophages. Pharmacol Res. 2005;51(6):539\u201346. doi: 10.1016/j.phrs.2005.02.002.", "ArticleIdList": ["10.1016/j.phrs.2005.02.002", "15829434"]}, {"Citation": "Sarkar D, Saha P, Gamre S, Bhattacharjee S, Hariharan C, Ganguly S, Sen R, Mandal G, Chattopadhyay S, Majumdar S. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-\u03baB pathway. Int Immunopharmacol. 2008;8(9):1264\u201371. doi: 10.1016/j.intimp.2008.05.003.", "ArticleIdList": ["10.1016/j.intimp.2008.05.003", "18602073"]}, {"Citation": "Iyer AKV, Rojanasakul Y, Azad N. Nitrosothiol signaling and protein nitrosation in cell death. Nitric Oxide Biol Chem. 2014;42:9\u201318. doi: 10.1016/j.niox.2014.07.002.", "ArticleIdList": ["10.1016/j.niox.2014.07.002", "PMC4258442", "25064181"]}, {"Citation": "Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. 2019;10(3):177. doi: 10.1038/s41419-019-1407-6.", "ArticleIdList": ["10.1038/s41419-019-1407-6", "PMC6384907", "30792387"]}, {"Citation": "Cullen SP, Martin SJ. Caspase activation pathways: some recent progress. Cell Death Differ. 2009;16(7):935\u20138. doi: 10.1038/cdd.2009.59.", "ArticleIdList": ["10.1038/cdd.2009.59", "19528949"]}, {"Citation": "Zhu J, Yang Y, Wu J. Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis. Cell Res. 2007;17(5):441\u20138. doi: 10.1038/cr.2007.36.", "ArticleIdList": ["10.1038/cr.2007.36", "17452997"]}, {"Citation": "Semwal DK, Kumar A, Aswal S, Chauhan A, Semwal RB. Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreatic \u03b2-cells and restoring their dysfunction. Phytother Res. 2021;35(3):1218\u201329. doi: 10.1002/ptr.6885.", "ArticleIdList": ["10.1002/ptr.6885", "32987447"]}, {"Citation": "Ok S, Kang JS, Kim KM. Cultivated wild ginseng extracts upregulate the anti-apoptosis systems in cells and mice induced by bisphenol A. Mol Cell Toxicol. 2017;13(1):73\u201382. doi: 10.1007/s13273-017-0008-7.", "ArticleIdList": ["10.1007/s13273-017-0008-7"]}, {"Citation": "Baharara J, Namvar F, Ramezani T, Mousavi M, Mohamad R. Silver nanoparticles biosynthesized using Achillea biebersteinii flower extract: apoptosis induction in MCF-7 cells via caspase activation and regulation of bax and bcl-2 gene expression. Molecules. 2015;20(2). 10.3390/molecules20022693.", "ArticleIdList": ["PMC6272258", "25665064"]}, {"Citation": "Bali EB, A\u00e7\u0131k L, El\u00e7i P, Sarper M, Avcu F, Vural M. In vitro anti-oxidant, cytotoxic and pro-apoptotic effects of Achillea Teretifolia Willd extracts on human prostate cancer cell lines. Pharmacogn Mag. 2015;11(Suppl 2):308\u2013S315. doi: 10.4103/0973-1296.166060.", "ArticleIdList": ["10.4103/0973-1296.166060", "PMC4653342", "26664020"]}, {"Citation": "Okkay U, Ferah Okkay I, Aydin IC, Bayram C, Ertugrul MS, Gezer A, Hacimuftuoglu A. Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study. Cutan Ocul Toxicol. 2021;40(3):214\u201320. doi: 10.1080/15569527.2021.1919137.", "ArticleIdList": ["10.1080/15569527.2021.1919137", "34180746"]}, {"Citation": "Ali SI, Gopalakrishnan B, Venkatesalu V. Pharmacognosy, phytochemistry and pharmacological properties of Achillea millefolium L.: a review. Phytother Res. 2017;31(8):1140\u201361. doi: 10.1002/ptr.5840.", "ArticleIdList": ["10.1002/ptr.5840", "28618131"]}, {"Citation": "Baretta IP, Felizardo RA, Bimbato VF, Santos MGJd, Kassuya CAL, Gasparotto Junior A, da Silva CR, de Oliveira SM, Ferreira J, Andreatini R. Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract. J Ethnopharmacol. 2012;140(1):46\u201354. doi: 10.1016/j.jep.2011.11.047.", "ArticleIdList": ["10.1016/j.jep.2011.11.047", "22155391"]}]}], "History": [{"Year": "2023", "Month": "8", "Day": "5"}, {"Year": "2024", "Month": "1", "Day": "3"}, {"Year": "2024", "Month": "1", "Day": "15", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "14", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "13", "Hour": "23", "Minute": "17"}, {"Year": "2024", "Month": "1", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["38218845", "PMC10790267", "10.1186/s12906-024-04335-2", "10.1186/s12906-024-04335-2"]}}]}